Simple Summary: Using hospital data that cover a highly diverse population of around three million in Southeast London and Kent, this study showed the associations of the glioma molecular markers of IDH1 mutation and MGMT promoter methylation with a patient’s age, sex, ethnicity, tumour histology, brain location and extent of resection. This evidence concerns the gene IDH1 and central nervous system cancer.